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Abstract
Background: Memokath urethral sphincter stents are used to facilitate bladder emptying in
patients with spinal cord injury, but long term follow-up has not been reported.
Methods: Case series of ten men with spinal cord injury who underwent insertion of Memokath
stents and were followed for up to nine years.
Results: Within four years, the stent had to be removed in nine out of ten patients because of:
extensive mucosal proliferation causing obstruction to the lumen of the stent; stone around the
proximal end of the stent, incomplete bladder emptying, and recurrent urinary infections; migration
of the stent into the bladder related to digital evacuation of bowels; large residual urine;
concretions within the stent causing obstruction to flow of urine, and partial blockage of the stent
causing frequent episodes of autonomic dysreflexia. In one patient the stent continued to function
satisfactorily after nine years.
Conclusions: The Memokath stent has a role as a temporary measure for treatment of detrusor-
sphincter dyssynergia in selected SCI patients who do not get recurrent urinary infection and do not
require manual evacuation of bowels.
Background
We reported our preliminary experience of using the
Memokath urethral stent to facilitate bladder emptying in
ten men with spinal cord injury. [1]. During follow-up of
3 to 7 months, results were satisfactory. This article reports
extended follow-up of nine years.
Methods
Selection of patients
Men with spinal cord injury and urinary retention due to
detrusor-sphincter dyssynergia were selected for insertion
of a Memokath urethral sphincter stent. The exclusion cri-
teria, inclusion criteria, technique for insertion and after
care are discussed in our previous publication [1]. All 10
men who underwent stenting achieved satisfactory blad-
der emptying and were followed for up to nine years.
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Results
Patient 1 developed difficulty in passing urine five
months after stent insertion. Cystoscopy revealed mucosal
oedema at the distal end of the stent. Fulguration of the
prouting mucosal tissue was performed and he was able to
pass urine satisfactorily. Four months later, he again de-
veloped difficulty in passing urine. Cystoscopy showed
extensive mucosal proliferation, obstructing the stent.
There was no encrustation and no stone. The stent was re-
moved. Eight years later, this patient is using a penile
sheath and supplementary intermittent catheterisation.
Patient 2 noticed spasms and sweating about four years af-
ter stent insertion. Ultrasound scan showed residual urine
in the bladder and a large stone around the proximal end
of the stent. Cystoscopy revealed stricture at the bulbo-
membranous urethra. Suprapubic cystostomy was done
and the stent was removed.
Patient 3 developed sweating and difficulty in emptying
his bladder eight months after stent insertion. Flexible cys-
toscopy showed the stent lying in the bladder. Probably,
digital bowel evacuation performed against the anterior
wall of the rectum (and the urethra) caused upward mi-
gration of the stent. The stent was removed from the blad-
der endoscopically, and indwelling urethral catheter
drainage was established.
Patient 4 was admitted nine months after stent insertion
with sweating and a moderately large bladder. The stent
was removed endoscopically. There was no calcification
around the stent. A sacral anterior root stimulator was im-
planted.
Patient 5 developed difficulty in passing urine about a
year after stent insertion while he was on holiday abroad.
Multiple unsuccessful attempts were made to insert a cath-
eter per urethra. Suprapubic cystostomy was performed.
Five months later, cystoscopy showed multiple false pas-
sages in the urethra. Concretions were present over the
Figure 1
X-ray of urinary bladder of case number 7 (25061996) shows
calcification around proximal end of stent within the urinary
bladder.
Figure 2
X-ray of urinary bladder of case number 9 (13031995) shows
stone formation around proximal end of stent. There is
some upward migration of the stent in to the urinary blad-
der.BMC Urology 2002, 2 http://www.biomedcentral.com/1471-2490/2/12
Page 3 of 4
(page number not for citation purposes)
stent. He underwent urethrotomy, division of external
sphincter, and transurethral resection of the bladder neck.
Patient 6 developed progressive difficulty in bladder emp-
tying seven months after insertion of a stent. The stent was
removed with a cystoscope. During removal, the stent was
found to be patent and in the proper position, with no
concretions. This patient is now using intermittent cathe-
terisation.
Patient 7 developed urinary infections 30 months after in-
sertion of a Memokath stent. X-ray of the urinary bladder
revealed a stone around the proximal end of the stent.
(Figure 1). Suprapubic cystostomy was performed. After
cooling the stent with ice cold saline, the stent and the
stone were removed. The patient is now using a penile
sheath drainage, and intermittent catheterisation.
Patient 8 noticed intermittent partial obstruction of the
stent about two years after it was inserted. During these
episodes he experienced sweating. The stent was removed
and a sacral anterior root stimulator was implanted.
Patient 9 developed recurrent urinary infections. Intrave-
nous urography performed 18 months after insertion of a
Memokath stent, revealed poor visualisation of the uri-
nary bladder due to dilute contrast. There was calcification
along the proximal portion of the stent. (Figure 2). Su-
prapubic cystostomy was done. The stent was cooled and
the distal portion was withdrawn easily from the prostatic
urethra. The remainder of the stent, along with a pear-
shaped stone, was removed from the bladder through the
suprapubic wound. This patient now performs intermit-
tent catheterisation.
Patient 10 had been passing urine satisfactorily through a
penile sheath for nearly nine years after insertion of Mem-
okath stent. (Figure 3). Recently he had to press the su-
prapubic region to pass urine. He did not have urinary
infections. X-ray of urinary bladder, taken six years after
Figure 3
X-ray of urinary bladder in case number 10 (03081993),
taken soon after insertion of Memokath stent, shows satisfactory
positioning of the stent.
Figure 4
X-ray of urinary bladder in case number 10, taken six years
after insertion of Memokath stent (16041999), shows stent in
place in the prostatic urethra. There is slight uncoiling of the
stent at one place.BMC Urology 2002, 2 http://www.biomedcentral.com/1471-2490/2/12
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insertion of Memokath stent showed slight uncoiling at
one place. (Figure 4). X-ray of urinary bladder, taken nine
years after insertion of Memokath stent (Figure 5),
showed that the stent had uncoiled itself slightly at two
places. This patient is currently under observation.
Discussion
It is possible that physicians using a new medical device
or carrying out a new surgical procedure may be reluctant
to publish their failures, as publication of complications
may amount to admission of professional incompetence.
Unless complications of a procedure are reported and in-
formation regarding potential complications is made
available to other health professionals, a procedure may
continue to be carried out by physicians without incorpo-
rating necessary modifications, thus compromising pa-
tients' safety. We favour voluntary reporting of all adverse
events as they occur in the course of clinical practice in a
spinal injuries centre. [2–5]. As we became aware of long-
term complications of Memokath urethral sphincter stent,
we stopped using Memokath stent in the Regional Spinal
Injuries Centre, Southport. We believe that Memokath
stent has a role as a temporary measure to cure detrusor-
sphincter dyssynergia in selected SCI patients, who do not
get recurrent urinary infection, and do not require manual
evacuation of bowels.
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Figure 5
X-ray of urinary bladder of case number 10, taken nine years
after insertion of Memokath stent (27082002), shows stent in
place in the prostatic urethra. Now there is slight uncoiling of
the stent at two places.